Nick Tate
Nick Tate Senior Editorial Manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.
Nick Tate is the senior editorial manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.
As a best-selling author, seasoned journalist and TV commentator specializing in health care, finance and biotech, Nick is all about big ideas and innovations — always keeping his followers informed on the next big thing.
His work has appeared in The Miami Herald, The Atlanta Journal-Constitution, South Florida Business Journal, Newsmax Magazine, South Florida Sun Sentinel, Boston Herald, and on Newsmax TV and the Al Jazeera network.
His top-selling book, the ObamaCare Survival Guide, was on the Publishers Weekly and The New York Times best-sellers lists for 22 weeks — reaching No. 1 on The Times list for paperback advice books.
Tate also co-authored DaVinci’s Baby Boomer Survival Guide: Live, Prosper, and Thrive in Your Retirement. And he published two other books — the Encyclopedia of Natural Healing and The Sick Building Syndrome — following a year-long journalism fellowship at the Harvard School of Public Health.
Tate’s three-decades-long commitment to keeping the public well-informed is why Banyan Hill Publishing recruited him in 2018 to join Paul Mampilly’s team. You can now read Nick’s weekly analysis in Bold Profits Daily as he guides over 130,000 readers on the best ways to grow their wealth.
Nick Tate's Articles
Chewy and Beyond Meat Spotlight Sizzling IPO Opportunities June 14, 2019 Bold Profits Daily, Investment Opportunities, Stocks - Today, Bold Profits IPO analyst Hudson Cashdan talks up the new Chewy public offering and tells Nick Tate why Beyond Meat has been such a superstar stock since going public on May 1. Plus: a preview of Bold Profits’ new IPO Speculator service. 
Meet Pepper: The New Face of AI Robotics June 7, 2019 Bold Profits Daily, Investment Opportunities, Technology - Artificially intelligent robots and other “thinking” machines are entering the workforce in health care, banking and retail. They can not only help you with your health, finances and store purchases, but offer a great investment opportunity too.
271% Gain in 2 Weeks From Biotech Rebound May 31, 2019 Bold Profits Daily, Investment Opportunities, Trading Strategies - See how you could gain 271% in two weeks using Paul’s Wall Street insider strategy, designed to beat market manipulators at their own game. 
Buy Into Stocks That Are Rebounding for Rocket Returns May 24, 2019 Bold Profits Daily, Stocks, Trading Strategies - “Buy low, sell high.” It’s investors’ mantra. But this one trick that market manipulators use to drive stock prices down can help you spot the right ones at the right time — just as they’re about to skyrocket.
Meatless Burger IPO Nets Investor-Advocate 1,570% Gains May 17, 2019 Bold Profits Daily, Investment Opportunities, Stocks - Beyond Meat’s stock skyrocketed 163% when it went public earlier this month. It’s proof the global market for meatless foods is booming and that IPOs are a great way to invest in companies and causes you believe in — and pocket big profits at the same time.
TransMedics’ $105 Million IPO Spotlights Organ Transplant Opportunity May 10, 2019 Bold Profits Daily, Investment Opportunities, Technology - The global organ-transplantation market is projected to hit $51 billion in just six years. Here’s how to double your money and cash in with an ETF, and double your money in a year.
2 Genome Sequencing Stocks to Buy Today May 2, 2019 Bold Profits Daily, Investment Opportunities, Technology - The market for full-genome DNA testing will hit 60 million by 2021 with a new $100 test in the pipeline — a milestone likely to deliver huge gains to investors who get in on this mega medical trend now.
Beyond Meat IPO – A Stock Play for the Meatless Burger Boom April 26, 2019 Bold Profits Daily, Investment Opportunities, Trending - Beyond Meat could be valued at $1.2 billion when it goes public. It’s proof the global market for meatless foods is booming. With 40 million Americans going vegan or vegetarian, now’s the time to buy into the mega meatless trend.
4,500% Biotech Opportunity: Needle-Free Diabetes Devices April 19, 2019 Bold Profits Daily, Investment Opportunities, Technology - We are at the forefront of a massive biotech opportunity. Two big diabetes advances are going to make needles obsolete, and investors wealthy.
2 Telehealth Stocks to Capitalize on Sector Growth April 12, 2019 Bold Profits Daily, Investment Opportunities, Technology - Telemedicine is reviving the idea of a house call, letting teledocs “meet” with patients via video. With telehealth set to become a $130 billion industry by 2025, now’s a great time to capitalize on the investment and health care opportunity it presents.
